MurrayE, JonesD. Audit into blood-borne virus services in Her Majesty's Prison Service. Int J STD AIDS2008;19:347–8
2.
AllwrightS, BradleyF, LongJ, BarryJ, ThorntonL, ParryJV. Prevalence of antibodies to hepatitis B, hepatitis C and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ2000;321:78–82
3.
CroftsN, StewartT, HearneP, PingXY, BreshkinAM, LocarniniSA. Spread of blood-borne viruses among Australian prison entrants. Br Med J1995;310:285–8
4.
ChongVH, JamaludinAZ, JacobAP, JalihalA. Treating intravenous drug users with hepatitis C infection: an opportunity in some settings. Eur J Gastroenterol Hepatol2006;18:1121
5.
RobaeysG, Van VlierbergheH, MatheïC, Van RanstM, BruckersL, BuntinxFBASL Steering Committee; Benelux Study Group. Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes. Eur J Gastroenterol Hepatol2006;18:159–66
